Medivolve Inc. (“Medivolve” or the “Company”) (NEO: MEDV; OTC: MEDVF; FRA:4NC) announces today that Dr. Beverley Richardson has resigned from its board of directors, effective immediately. The Company intends to announce the appointment of Dr. Richardson’s replacement in the near future. Management and the board would like to thank Dr. Richardson for her services and extensive contributions to the Company and wish her well in her future endeavours.

About Medivolve Inc.

Medivolve is a Canadian healthcare technology company headquartered in Toronto, Canada. The Company’s mission is to improve health and lives by delivering world-class diagnostic solutions—starting with COVID-19—as well as to enable faster and better care to patients through innovative technology. Medivolve, through its subsidiaries, operates retail patient-care locations in California.

For investing inquiries, please contact: David Preiner, CEO, info@medivolve.ca, 702-990-3737.

Cautionary Note Regarding Forward-looking Information

This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation. Forward-looking information includes, but is not limited to, statements with respect to the appointment of directors. Generally, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will be taken", "occur" or "be achieved". Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company, as the case may be, to be materially different from those expressed or implied by such forward-looking information, including (but not limited to) the Company’s ability to attract and retain qualified personnel. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws.

Medivolve (NEO:MEDV)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Medivolve Charts.
Medivolve (NEO:MEDV)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Medivolve Charts.